Long-term follow-up of the effect of delayed-release dimethyl fumarate on no evident disease activity in patients with multiple sclerosis

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2014
This article has no abstract
Epistemonikos ID: 1cee25bf313b91becb728966646256db03c9dd89
First added on: Apr 30, 2026